| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 83,071 | 79,041 | 75,309 | 73,021 | | Cost of Revenue | 23,382 | 23,802 | 21,520 | 19,463 | | | Gross Profit | 59,689 | 55,239 | 53,789 | 53,558 | | | Operating Expenses | | Research Development | 3,823 | 3,145 | 2,776 | 2,897 | | Selling General and Administrative | 21,457 | 21,848 | 20,644 | 21,729 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,067 | 1,072 | 1,071 | 1,071 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 33,342 | 29,174 | 29,298 | 27,861 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 220 | 429 | 114 | (644) | | Earnings Before Interest And Taxes | 33,562 | 29,603 | 29,412 | 27,217 | | Interest Expense | 5 | 5 | 42 | 76 | | Income Before Tax | 33,557 | 29,598 | 29,370 | 27,141 | | Income Tax Expense | 12,224 | 10,166 | 9,914 | 9,802 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 21,333 | 19,432 | 19,456 | 17,339 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 21,333 | 19,432 | 19,456 | 17,339 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $21,333 | $19,432 | $19,456 | $17,339 |
|
0.19% Nasdaq 
Income Statement
